Insider Transactions in Q4 2025 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,889
-3.59%
|
$122,785
$65.3 P/Share
|
|
Dec 31
2025
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,326
+7.6%
|
-
|
|
Dec 31
2025
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,558
-2.9%
|
$166,270
$65.3 P/Share
|
|
Dec 31
2025
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,724
+8.99%
|
-
|
|
Dec 26
2025
|
Quan Anh Vu Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+50.0%
|
$103,500
$69.95 P/Share
|
|
Dec 18
2025
|
Arthur J Klausner Director |
SELL
Open market or private sale
|
Direct |
5,121
-19.28%
|
$343,107
$67.57 P/Share
|
|
Dec 16
2025
|
Arthur J Klausner Director |
BUY
Other acquisition or disposition
|
Direct |
7,710
+35.71%
|
-
|
|
Dec 16
2025
|
Diane Hendricks > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
43,499
-7.12%
|
-
|